Abstract
Background
Practices regarding recovery after mastectomy vary significantly, including overnight stay versus discharge same day. Expanded use of Enhanced Recovery After Surgery (ERAS) algorithms and the recent COVID pandemic have led to increased number of patients who undergo home recovery after mastectomy (HRAM).
Methods
The Patient Safety Quality Committee of the American Society of Breast Surgeons created a multispecialty working group to review the literature evaluating HRAM after mastectomy with and without implant-based reconstruction. A literature review was performed regarding this topic; the group then developed guidance for patient selection and tools for implementation.
Results
Multiple, retrospective series have reported that patients discharged day of mastectomy have similar risk of complications compared with those kept overnight, including risk of hematoma (0-5.1%). Multimodal strategies that improve nausea and analgesia improve likelihood of HRAM. Patients who undergo surgery in ambulatory surgery centers and by high-volume breast surgeons are more likely to be discharged day of surgery. When evaluating unplanned return to care, the only significant factors are African American race and increased comorbidities.
Conclusions
Review of current literature demonstrates that HRAM is a safe option in appropriate patients. Choice of method of recovery should consider patient factors, such as comorbidities and social situation, and requires input from the multidisciplinary team. Preoperative education regarding pain management, drain care, and after-hour access to medical care are crucial components to a successful program. Additional investigation is needed as these programs become more prevalent to assess quality measures such as unplanned return to care, complications, and patient satisfaction.
Similar content being viewed by others
References
Warren JA, Potosky AL, Klabunde CN, et al. Trends and outcomes of outpatient mastectomy in elderly women. JNCI. 1998;90(11):833–40.
Centers for Disease Control. 2000. https://stacks.cdc.gov/view/cdc/41564/cdc_41564_DS1. Accessed 3 July 2021.
Arsalani-Zadeh R, ELFadl D, Yassin N, MacFie J. Evidence-based review of enhancing postoperative recovery after breast surgery. Br J Surg. 2011;98(2):181–96.
Grant MC, Pio Roda CM, Canner JK, et al. The impact of anesthesia-influenced process measure compliance on length of stay: results from an enhanced recovery after surgery for colorectal surgery cohort. Anesth Analg. 2019;128(1):68–74.
Smith TW Jr, Wang X, Singer MA, Godellas CV, Vaince FT. Enhanced recovery after surgery: a clinical review of implementation across multiple surgical subspecialties. Am J Surg. 2020;219(3):530–4.
Rojas KE, Fortes TA, Manasseh DM, Andaz C, Borgen PI. Mastectomy is no longer an indication for postoperative opioid prescription at discharge. Am J Surg. 2019;218(4):700–5.
Rojas KE, Manasseh DM, Flom PL, et al. A pilot study of a breast surgery Enhanced Recovery After Surgery (ERAS) protocol to eliminate narcotic prescription at discharge. Breast Cancer Res Treat. 2018;171(3):621–6.
Steiner CA, Weiss AJ, Barrett ML, Fingar KR, Davis PH. Trends in Bilateral and Unilateral Mastectomies in Hospital Inpatient and Ambulatory Settings, 2005–2013. HCUP Statistical Brief #201. February 2016.
Cordeiro E, Jackson T, Cil T. Same-day major breast cancer surgery is safe: an analysis of short-term outcomes using NSQIP data. Ann Surg Oncol. 2016;23:2480–6.
Bartlett DL, Howe JR, Chang G, et al. Management of cancer surgery cases during the COVID-19 pandemic: considerations. Ann Surg Oncol. 2020;27:1717–20.
Cortina CS, Ward EP, Kong AL. The consideration for outpatient mastectomy during the Covid-19 global pandemic. Am J Surg. 2021. https://doi.org/10.1016/j.amjsurg.2020.12.043.
Vuong B, Dusendang JR, Chang SB, et al. Outpatient mastectomy: factors influencing patient selection of predictors of return to Care. J Am Coll Surg. 2020;232(1):35–44.
Jogerst K, Thomas O, Kosiorek HE, et al. Same-day discharge after mastectomy: breast cancer surgery in the era of ERAS®. Ann Surg Oncol. 2020;27(9):3436–45.
Specht M, Sobti N, Rosado N, et al. High-efficiency same-day approach to breast reconstruction during the COVID-19 crisis. Breast Cancer Res Treat. 2020;182(3):679–88.
Hammond JB, Thomas O, Jogerst K, et al. Same-day discharge is safe and effective after implant-based breast reconstruction. Ann Plast Surg. 2021;87(2):144–9.
Schwartz JC. Mastectomy and prepectoral reconstruction in an ambulatory surgery center reduces major infections complication rates. PRS Global Open. 2020;8(7):e2960.
Keehn AR, Olson DW, Dort JC, et al. Same-day surgery for mastectomy patients in Alberta: a perioperative care pathway and quality improvement initiative. Ann Surg Oncol. 2019;26(10):3354–60.
Dumestre DO, Redwood J, Webb CE, Temple-Oberle C. Enhanced Recovery After Surgery (ERAS) protocol enables safe same-day discharge after alloplastic breast reconstruction. Plast Surg (Oakv). 2017;25(4):249–54.
Oxley PJ, McNeely C, Janzen R, et al. Successful same day discharge after immediate post-mastectomy alloplastic breast reconstruction: a single tertiary centre retrospective audit. J Plast Rec Aesth Surg. 2020;73:1068–74.
Bakeer MA, Coker C, Atamian E, Yoo D, Torabi R, Riker A. A single-institution case series of outpatient same-day mastectomy: implementation of a quality improvement project and initiative for enhanced recovery after surgery. Ochsner J. 2020;20(4):388–93.
Qin C, Antony AK, Aggarwal A, Jordan S, Gutowski KA, Kim JY. Assessing outcomes and safety of inpatient versus outpatient tissue expander immediate breast reconstruction. Ann Surg Oncol. 2015;22:3724–9.
Marla S, Stallard S. Systematic review of day surgery for breast cancer. Int J Surg. 2009;7:318–23.
Brenin DR, Dietz JR, Baima J, et al. Pain management in breast surgery: recommendations of a multidisciplinary expert panel—the American Society of Breast Surgeons. Ann Surg Oncol. 2020;27(12):4588–602.
Manahan MA, Basdag B, Kalmar CL, et al. Risk of severe and refractory postoperative nausea and vomiting in patients undergoing DIEP flap breast reconstruction. Microsurgery. 2014;34:112–21.
Gan TJ, Belani KG, Bergese S, et al. Fourth consensus guidelines for the management of postoperative nausea and vomiting. Anesth Analg. 2020;131(2):411–48.
Gupta P, Jain S. Postoperative nausea and vomiting prophylaxis: a comparative study of ondansetron, granisetron and granisetron and dexamethasone combination after modified radical mastectomy. Saudi J Anaesth. 2014;8(Suppl 1):S67-71.
Schraag S, Pradelli L, Alsaleh AJO, et al. Propofol vs inhalational agents to maintain general anaesthesia in ambulatory and in-patient surgery: a systematic review and meta-analysis. BMC Anesthesiol. 2018;18(162):1–9.
Barker JC, DiBartola K, Wee C, et al. Preoperative multimodal analgesia decreases postanesthesia care unit narcotic use and pain scores in outpatient breast surgery. Plast Reconstr Surg. 2018;142:443e–50e.
De Oliveira GS, Rodes ME, Bialek J, Kendall MC, McCarthy RJ. Single dose systemic acetaminophen to improve patient reported quality of recovery after ambulatory segmental mastectomy: a prospective, randomized, double-blinded, placebo controlled, clinical trial. Breast J. 2018;24(3):240–4.
Plunkett A, Haley C, McCoart A, et al. A preliminary examination of the comparative efficacy of intravenous vs oral acetaminophen in the treatment of perioperative pain. Pain Med. 2017;18:2466–73.
van der Westhuizen J, Kuo PY, Reed PW, Holder K. Randomised controlled trial comparing oral and intravenous paracetamol (acetaminophen) plasma levels when given as preoperative analgesia. Anaesth Intensive Care. 2011;39:242–6.
Bourgeois FT, Graham DA, Kesselheim AS, Randolph AG. Cost implications of escalating intravenous acetaminophen use in children. JAMA Pediatr. 2019;173:489–91.
Mitchell A, McCrea P, Inglis K, Porter G. A randomized, controlled trial comparing acetaminophen plus ibuprofen versus acetaminophen plus codeine plus caffeine (Tylenol 3) after outpatient breast surgery. Ann Surg Oncol. 2012;19(12):3792–800. https://doi.org/10.1245/s10434-012-2447-7.
Parsa AA, Sprouse-Blum AS, et al. Combined preoperative use of celecoxib and gabapentin in the management of postoperative pain. Aesthetic Plast Surg. 2009;33:98–103.
Sun T, Sacan O, White PF, Coleman J, Rohrich RJ, Kenkel JM. Perioperative versus postoperative celecoxib on patient outcomes after major plastic surgery procedures. Anesth Analg. 2008;106:950–8.
Walker NJ, Jones VM, Kratky L, Chen H, Runyan CM. Hematoma risks of nonsteroidal anti-inflammatory drugs used in plastic surgery procedures: a systematic review and meta-analysis. Ann Plast Surg. 2019;82:S437–45.
Rojas KE, Fortes TA, Flom P, Manasseh DM, Andaz C, Borgen P. Intraoperative ketorolac use does not increase the risk of bleeding in breast surgery. Ann Surg Oncol. 2019;26:3368–73.
Nguyen BN, Barta RJ, Stewart CE, Wheelwright M, Heinrich CA. Ketorolac for patients undergoing implant-based breast reconstruction: impact on hospital length of stay and postoperative narcotic use. Aesthet Surg J. 2020;40:174–9.
Bourazani M, Papageorgiou E, Zarkadas G, et al. The role of muscle relaxants: spasmolytic (thiocochlicoside) in postoperative pain management after mastectomy and breast reconstruction. Asian Pac J Cancer Prev. 2019;20:743–9.
Amr YM, Yousef AA. Evaluation of efficacy of the perioperative administration of venlafaxine or gabapentin on acute and chronic postmastectomy pain. Clin J Pain. 2010;26:381–5.
Dirks J, Fredensborg BB, Christensen D, Fomsgaard JS, Flyger H, Dahl JB. A randomized study of the effects of single-dose gabapentin versus placebo on postoperative pain and morphine consumption after mastectomy. Anesthesiology. 2002;97:560–4.
Grover VK, Mathew PJ, Yaddanapudi S, Sehgal S. A single dose of preoperative gabapentin for pain reduction and requirement of morphine after total mastectomy and axillary dissection: randomized placebo-controlled double-blind trial. J Postgrad Med. 2009;55:257–60.
Hah J, Mackey SC, Schmidt P, et al. Effect of perioperative gabapentin on postoperative pain resolution and opioid cessation in a mixed surgical cohort: a randomized clinical trial. JAMA Surg. 2018;153:303–11.
Jiang Y, Li J, Lin H, et al. The efficacy of gabapentin in reducing pain intensity and morphine consumption after breast cancer surgery: a meta-analysis. Med Baltim. 2018;97:e11581.
Rai AS, Khan JS, Dhaliwal J, et al. Preoperative pregabalin or gabapentin for acute and chronic postoperative pain among patients undergoing breast cancer surgery: a systematic review and meta-analysis of randomized controlled trials. J Plast Reconstr Aesthet Surg. 2017;70:1317–28.
Kim SY, Song JW, Park B, Park S, An YJ, Shim YH. Pregabalin reduces postoperative pain after mastectomy: a double-blind, randomized, placebo-controlled study. Acta Anaesthesiol Scand. 2011;55:290–6.
Verret M, Lauzier F, Zarychanski R, et al. Perioperative use of gabapentinoids for the management of postoperative acute pain: a systematic review and meta-analysis. Anesthesiology. 2020;133:265–79.
Hamilton TW, Athanassoglou V, Mellon S, et al. Liposomal bupivacaine infiltration at the surgical site for the management of postoperative pain. Cochrane Database Syst Rev. 2017;2(2):CD011419.
Woodworth GE, Ivie RMJ, Nelson SM, Walker CM, Maniker RB. Perioperative breast analgesia: a qualitative review of anatomy and regional techniques. Reg Anesth Pain Med. 2017;42(5):609–31.
Cheng GS, Ilfeld BM. A review of postoperative analgesia for breast cancer surgery. Pain Manag. 2016;6(6):603–18.
Rao R, Jackson RS, Rosen B, et al. Pain control in breast surgery: survey of current practice and recommendations for optimizing management—American Society of Breast Surgeons Opioid/Pain Control Workgroup. Ann Surg Oncol. 2020;27:985–90.
Layeeque R, Hochberg J, Siegel E, et al. Botulinum toxin infiltration for pain control after mastectomy and expander reconstruction. Ann Surg. 2004;240(4):608–13.
Antony AK, Poirier J, Madrigrano A, Kopkash KA, Robinson EC. Evolution of the surgical technique for “Breast in a Day” direct-to-implant breast reconstruction: transitioning from dual-plane to prepectoral implant placement. Plast Reconstr Surg. 2019;143(6):1547–56.
Sigalove S, Maxwell GP, Sigalove NM, et al. Prepectoral implant-based breast reconstruction: rationale, indications, and preliminary results. Plast Reconstr Surg. 2017;139(2):287–94.
Casella D, Kaciulyte J, Lo Torto F, et al. “To Pre or Not to Pre”: introduction of a prepectoral breast reconstruction assessment score to help surgeons solving the decision-making dilemma retrospective results of multicenter experience. Plast Reconstr Surg. 2021;147(6):1278–86.
Neville A, Lee L, Antonescu I, et al. Systematic review of outcomes used to evaluate enhanced recovery after surgery. Br J Surg. 2014;101(3):159–70.
Fiore JF Jr, Faragher IG, Bialocerkowski A, Browning L, Denehy L. Time to readiness for discharge is a valid and reliable measure of short-term recovery after colorectal surgery. World J Surg. 2013;37:2917–34.
Acknowledgment
The authors thank Mena Jalali and Sharon Grutman for their administrative efforts on this project and the Executive Board of the American Society of Breast Surgeons for its support of this workgroup. They also thank Sara Fluharty (perioperative nursing representative) and Eileen Fuentes (patient advocate) for their participation in this project.
Author information
Authors and Affiliations
Consortia
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ludwig, K., Wexelman, B., Chen, S. et al. Home Recovery After Mastectomy: Review of Literature and Strategies for Implementation American Society of Breast Surgeons Working Group. Ann Surg Oncol 29, 5799–5808 (2022). https://doi.org/10.1245/s10434-022-11799-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-022-11799-4